We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toOptimize Your RWE Investments through a Platform Based Approach

Optimize Your RWE Investments through a Platform Based Approach


Overview

This Solution Provider Webinar is brought to you by DIA in cooperation with CitiusTech


With the increasing drug development cost, shift from volume to value-based pricing and competition from generics and biosimilars, pharma and life science organizations are looking towards real world evidence (RWE) to prove the value – cost, safety, and effectiveness of their medicinal products. However, the current real-world data comes in structured and unstructured format, in various data standards, and is laden with varied data quality issues. The industry is looking to define a platform-based approach to address the functional and technical complexities of RWE and harness the real-world datasets across the pharma value chain.
Join us for an intriguing presentation on “Optimize Your RWE Investments Through a Platform-Based Approach”, led by leading experts with multiple years of experience in CRO and technology industry.

Featured topics

  • Real World Evidence Dynamics, Challenges, and Considerations
  • Technological Approach for Effectively Leveraging RWE
  • Who should attend?

  • RWE
  • HEOR
  • Late Stage
  • Epidemiology in Pharma
  • CRO organizations
  • Learning objectives

  • Understand the key business use cases and stakeholders of RWE
  • Gather an industry perspective on RWE and its impact on entire pharma value chain
  • Current challenges and the need for a platform based approach
  • Understand the current state of RWE analytics implementation and associated complexity
  • Understand RWE business problem with respect to observational research
  • Get an overview of a platform-based approach to harness real-world datasets for observation research
  • Contact us

    Registration Questions?

    Send Email
    1.888.257.6457
    +1.215.442.6100